Literature DB >> 3116451

Cerebral perfusion pressure: a hemodynamic mechanism of mannitol and the postmannitol hemogram.

M J Rosner1, I Coley.   

Abstract

Sixteen patients each received infusions of 1 g of mannitol per kg over 5 to 10 minutes, and serial determinations of intracranial pressure (ICP), systemic arterial blood pressure (SABP), central venous pressure, cerebral perfusion pressure (CPP), hematocrit, hemoglobin, serum Na+, K+, osmolarity, and fluid balance were carried out for 4 hours. Urine output was replaced volume for volume with 5% dextrose in 0.45% NaCl solution. We tested the hypothesis that patients with high (greater than or equal to 70 torr) CPP would respond less well to mannitol by either ICP or CPP criteria than patients with low (less than 70 torr) CPP. The rationale for this hypothesis was based upon the association of low CPP with autoregulatory vasodilatation, whereas high CPP is associated with vasoconstriction. If mannitol should work by a vasoconstriction mechanism, the ICP effects should be most apparent under conditions of low CPP. Those patients with CPP greater than or equal to 70 torr responded relatively poorly to mannitol, with ICP decreasing from 25 +/- 4 to 17 +/- 5 (SE) mm Hg at 45 minutes postinfusion. Patients with CPP less than 70 responded with ICP declining from 35 +/- 5 to 13 +/- 4 mm Hg. The initial SABP was 81 +/- 5 mm Hg in the CPP less than 70 group and immediately rose to 90 +/- 7 at 15 minutes postmannitol. The SABP increase correlated with ICP (r = -0.40, P less than 0.01), but not when CPP greater than or equal to 70. SABP was significantly higher in the latter group (105 +/- 6) and increased to 107 +/- 8 postmannitol. The ICP decrease began immediately with the SABP increase. No mannitol "rebound" occurred in these patients. Measures of acute volume expansion all correlated with ICP (Na+, r = -0.67, P less than 0.001; hematocrit, r = -0.27, P less than 0.01; serum osmolarity, r = 0.32, P less than 0.05) when CPP less than 70 torr. None correlated with ICP when CPP greater than or equal to 70. These data suggest that mannitol infusion is at least partly dependent upon hemodynamic mechanisms that allow vasoconstriction to occur with reduction in cerebral blood volume and that little may be gained by using mannitol when CPP greater than or equal to 70 either by SABP, ICP, or CPP criteria because vasoconstriction is already nearly maximal. This mechanism is not exclusive of other potential mechanisms of action. Mannitol "rebound" may be a function of net dehydration, hemoconcentration, and SABP decline.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3116451     DOI: 10.1227/00006123-198708000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

Review 1.  Osmotic therapy: fact and fiction.

Authors:  Michael N Diringer; Allyson R Zazulia
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  Cerebral perfusion pressure and intracranial pressure in relation to neuropsychological outcome.

Authors:  E Lannoo; F Colardyn; C De Deyne; T Vandekerckhove; C Jannes; G De Soete
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

3.  Real-time hemodynamic response and mitochondrial function changes with intracarotid mannitol injection.

Authors:  Shailendra Joshi; Rajinder Singh-Moon; Mei Wang; Jeffrey N Bruce; Irving J Bigio; Avraham Mayevsky
Journal:  Brain Res       Date:  2014-01-15       Impact factor: 3.252

Review 4.  Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations.

Authors:  Mauro Oddo; Daniele Poole; Raimund Helbok; Geert Meyfroidt; Nino Stocchetti; Pierre Bouzat; Maurizio Cecconi; Thomas Geeraerts; Ignacio Martin-Loeches; Hervé Quintard; Fabio Silvio Taccone; Romergryko G Geocadin; Claude Hemphill; Carole Ichai; David Menon; Jean-François Payen; Anders Perner; Martin Smith; José Suarez; Walter Videtta; Elisa R Zanier; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2018-03-02       Impact factor: 17.440

5.  Cause, distribution and significance of episodes of reduced cerebral perfusion pressure following head injury.

Authors:  F Cortbus; P A Jones; J D Miller; I R Piper; J L Tocher
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

6.  Effect of mannitol on cerebral blood volume in patients with head injury.

Authors:  Michael N Diringer; Michael T Scalfani; Allyson R Zazulia; Tom O Videen; Rajat Dhar; William J Powers
Journal:  Neurosurgery       Date:  2012-05       Impact factor: 4.654

Review 7.  Hyperosmolar therapy for intracranial hypertension.

Authors:  Andrew Torre-Healy; Nicholas F Marko; Robert J Weil
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

8.  Accumulated mannitol and aggravated cerebral edema in a rat model of middle cerebral artery infarction.

Authors:  Jaeman Cho; Yeon-Hee Kim; Hyung Soo Han; Jaechan Park
Journal:  J Korean Neurosurg Soc       Date:  2007-10-20

9.  Formula for use of mannitol in patients with intracerebral haemorrhage and high intracranial pressure.

Authors:  Ge Tan; Jiying Zhou; Dongli Yuan; Shanquan Sun
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

10.  In vivo leukocyte-mediated brain microcirculatory inflammation: a comparison of osmotherapies and progesterone in severe traumatic brain injury.

Authors:  Kenichiro Kumasaka; Joshua A Marks; Rachel Eisenstadt; Mohammad A Murcy; Davoud Samadi; Shengjie Li; Victoria Johnson; Kevin D Browne; Douglas H Smith; C William Schwab; Jose L Pascual
Journal:  Am J Surg       Date:  2014-09-22       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.